Add a bookmark to get started
DLA Piper Represents Liquidia Corporation in US$100 Million Revenue Interest Financing...
30 January 2023 .2 minute read
DLA Piper advises Iovance Biotherapeutics, Inc. in its acquisition of Proleukin®
30 January 2023 .3 minute read
DLA Piper advises RoboBurger in its Seed 2 financing round
19 October 2022 .2 minute read